Cholera Vaccines Market
授權報價
| Single User License | $4,500 USD |
| Multiple User License | $5,500 USD |
| Custom Research License | $8,000 USD |
完整報告名稱與涵蓋範圍
Cholera Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Whole cell V. Cholerae O1 Recombinant With B-Subunit and Killed Oral O1 & O139), By Product (Vaxchora, Dukoral, Shanchol, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Others), By Region & Competition, 2021-2031F
報告摘要
Market Overview
The global cholera vaccines market is projected to expand significantly, growing from USD 97.32 Million in 2025 to USD 166.11 Million by 2031 at a 9.32% CAGR. These biological preparations, primarily oral formulations, induce immunity against the Vibrio cholerae bacterium. The market is propelled by the intensifying frequency of cholera outbreaks, largely attributed to climate change phenomena such as severe flooding and droughts that compromise water and sanitation infrastructure. The escalation of humanitarian crises and population displacement further necessitates rigorous mass vaccination campaigns to mitigate morbidity in high-risk zones, with over 40 million oral cholera vaccine doses allocated globally in 2025 to address surging outbreaks and humanitarian emergencies, according to the International Coordinating Group on Vaccine Provision.
Market Driver
The resurgence of cholera outbreaks in endemic regions, heavily influenced by climate change-induced events like severe floods and cyclones contaminating water, serves as the primary catalyst driving the market's urgent expansion. This escalation, which led to 409,222 cholera cases and over 4,700 deaths between January and August 2025 as reported by the WHO, has rapidly depleted existing stockpiles, creating an immediate need for replenishment and distribution. Additionally, advancements in vaccine formulation and the expansion of manufacturing infrastructure are reshaping supply dynamics; pharmaceutical companies and global alliances are investing in high-capacity production facilities and streamlining regulatory approvals, exemplified by Bharat Biotech's plan for 200 million doses annually and EuBiologics Co., Ltd's commitment to supply 72 million doses to UNICEF in 2025.
Market Challenge
Despite this robust demand and production efforts, the market faces a significant barrier: insufficient global production capacity relative to immediate public health requirements. This manufacturing bottleneck creates a hard ceiling on market volume, preventing the industry from capitalizing on demand, resulting in severe stockpile shortages, forced dose rationing strategies, delayed response times in endemic regions, and restricted geographical expansion. This persistent gap, where requests for 13.9 million doses in Q1 2025 alone rapidly depleted stock, remains the primary restraint hindering broader market expansion and timely disease elimination efforts.
Market Trends
In parallel, two key trends are influencing the market: the growth in the private travel market and prophylactic vaccination demand, offering a lucrative segment with higher price points from international tourists to endemic zones, as shown by Valneva SE's Dukoral vaccine sales growing to €17.4 million in H1 2025. Simultaneously, there's a diversification of the global manufacturing and supply base, shifting production geography to reduce reliance on Asian incumbents and enhance regional health security. This involves funding technology transfers to local manufacturers, particularly in Africa, to decentralize the supply chain and ensure indigenous end-to-end capabilities, such as Biovac in South Africa commencing Phase 1 clinical trials for its locally manufactured oral cholera vaccine in October 2025.
Key Market Players
* Valneva SE
* Sanofi S.A.
* Emergent BioSolutions Inc.
* EuBiologics Co., Ltd.
* Shantha Biotechnics Limited
* Hilleman Laboratories Singapore Pte Ltd
* Astellas Pharma Inc.
* Incepta Pharmaceuticals Ltd.
* Bharat Biotech Ltd.
* Takeda Pharmaceutical Company Limited
Report Scope
In this report, the Global Cholera Vaccines Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
# Cholera Vaccines Market, By Type
* Whole cell V. Cholerae O1 Recombinant With B-Subunit
* Killed Oral O1 & O139
# Cholera Vaccines Market, By Product
* Vaxchora
* Dukoral
* Shanchol
* Others
# Cholera Vaccines Market, By Distribution Channel
* Hospital Pharmacy
* Retail Pharmacy
* Others
# Cholera Vaccines Market, By Region
* North America
United States
Canada
Mexico
* Europe
France
United Kingdom
Italy
Germany
Spain
* Asia Pacific
China
India
Japan
Australia
South Korea
* South America
Brazil
Argentina
Colombia
* Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Cholera Vaccines Market.
Available Customizations:
Global Cholera Vaccines Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
* Detailed analysis and profiling of additional market players (up to five).
目錄 Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Cholera Vaccines Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Whole cell V. Cholerae O1 Recombinant With B-Subunit, Killed Oral O1 & O139)
5.2.2. By Product (Vaxchora, Dukoral, Shanchol, Others)
5.2.3. By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others)
5.2.4. By Region
5.2.5. By Company (2025)
5.3. Market Map
6. North America Cholera Vaccines Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Product
6.2.3. By Distribution Channel
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Cholera Vaccines Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By Product
6.3.1.2.3. By Distribution Channel
6.3.2. Canada Cholera Vaccines Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By Product
6.3.2.2.3. By Distribution Channel
6.3.3. Mexico Cholera Vaccines Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By Product
6.3.3.2.3. By Distribution Channel
7. Europe Cholera Vaccines Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Product
7.2.3. By Distribution Channel
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Cholera Vaccines Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Product
7.3.1.2.3. By Distribution Channel
7.3.2. France Cholera Vaccines Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Product
7.3.2.2.3. By Distribution Channel
7.3.3. United Kingdom Cholera Vaccines Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Product
7.3.3.2.3. By Distribution Channel
7.3.4. Italy Cholera Vaccines Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By Product
7.3.4.2.3. By Distribution Channel
7.3.5. Spain Cholera Vaccines Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By Product
7.3.5.2.3. By Distribution Channel
8. Asia Pacific Cholera Vaccines Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Product
8.2.3. By Distribution Channel
8.2.4. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Cholera Vaccines Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Product
8.3.1.2.3. By Distribution Channel
8.3.2. India Cholera Vaccines Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Product
8.3.2.2.3. By Distribution Channel
8.3.3. Japan Cholera Vaccines Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Product
8.3.3.2.3. By Distribution Channel
8.3.4. South Korea Cholera Vaccines Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By Product
8.3.4.2.3. By Distribution Channel
8.3.5. Australia Cholera Vaccines Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By Product
8.3.5.2.3. By Distribution Channel
9. Middle East & Africa Cholera Vaccines Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Product
9.2.3. By Distribution Channel
9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Cholera Vaccines Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Product
9.3.1.2.3. By Distribution Channel
9.3.2. UAE Cholera Vaccines Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Product
9.3.2.2.3. By Distribution Channel
9.3.3. South Africa Cholera Vaccines Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Product
9.3.3.2.3. By Distribution Channel
10. South America Cholera Vaccines Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By Product
10.2.3. By Distribution Channel
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Cholera Vaccines Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Product
10.3.1.2.3. By Distribution Channel
10.3.2. Colombia Cholera Vaccines Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By Product
10.3.2.2.3. By Distribution Channel
10.3.3. Argentina Cholera Vaccines Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By Product
10.3.3.2.3. By Distribution Channel
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Cholera Vaccines Market: SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Valneva SE
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Sanofi S.A.
15.3. Emergent BioSolutions Inc.
15.4. EuBiologics Co., Ltd.
15.5. Shantha Biotechnics Limited
15.6. Hilleman Laboratories Singapore Pte Ltd
15.7. Astellas Pharma Inc.
15.8. Incepta Pharmaceuticals Ltd.
15.9. Bharat Biotech Ltd.
15.10. Takeda Pharmaceutical Company Limited
16. Strategic Recommendations
17. About Us & Disclaimer
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 TechSci Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們